What is a common cause of constipation in clients undergoing peritoneal dialysis?

A common cause of constipation in clients undergoing peritoneal dialysis is the use of phosphate binders. Phosphate binders are medications that help manage elevated phosphate levels in individuals with kidney impairment, and they often contain aluminum or calcium, which can lead to gastrointestinal side effects, including constipation. As patients on peritoneal dialysis frequently have altered gastrointestinal function due to their treatment regimen, the addition of these binders can exacerbate the risk of constipation.

Furthermore, the nutritional management of clients undergoing peritoneal dialysis often necessitates dietary adjustments that can also contribute to constipation. While a high-protein diet can be essential for maintaining nutritional status in these patients, it can also lead to lower fiber intake if not balanced properly. Therefore, phosphate binders represent a direct pharmacological factor associated with constipation in this specific population.